Digestive Diseases and Sciences

, Volume 57, Issue 5, pp 1420–1422

The Impact of Population-Based Screening Studies on Hemochromatosis Screening Practices

  • Natasha Chandok
  • Mark Speechley
  • Peter J. Ainsworth
  • Subrata Chakrabarti
  • Paul C. Adams
Correspondence

Abstract

Objectives

To determine if community population screening studies for hemochromatosis affected HFE genetic screening practices in non-study populations.

Methods

An audit of all genetic testing for HFE mutations at London Health Sciences Center, London, Ontario, Canada from 1997 to 2010 was performed. The frequency of genetic testing and the frequency of C282Y homozygous cases identified during the years of the London Red Cross (1998–1999) and HEIRS (2000–2005) screening studies were compared with the corresponding frequencies in the specified years outside this range (1997–1998 and 2006–2010).

Results

An increase in HFE gene mutation testing is seen during the London Red Cross study, and the frequency of testing rose further during the HEIRS study. Genetic screening activity continued to increase in the years after publication of the HEIRS study. The proportion of patients with homozygosity for C282Y mutation remained relatively constant despite fluctuations in numbers of persons screened per annum.

Conclusions

The rise in HFE gene testing among non-study populations during the HH studies could be explained by the Hawthorne effect, a phenomenon referring to the improvement or modification of behavior by a population as a consequence of it being studied. In this case, we postulate that primary care physicians at our center performed more HFE gene tests for their patients as a consequence of being affected by knowledge of the screening studies. Despite a general increase in testing during and after completion of the studies, the total number of hemochromatosis cases (C282Y homozygotes) diagnosed per annum remained relatively constant.

Keywords

Hemochromatosis Screening Hawthorne effect 

Reference

  1. 1.
    Adams PC, Kertesz AE, McLaren C, Barr R, Bamford A, Chakrabarti S. Population screening for hemochromatosis: a comparison of unbound iron binding capacity, transferrin saturation and C282Y genotyping in 5, 211 voluntary blood donors. Hepatology. 2000;31:1160–1164.PubMedCrossRefGoogle Scholar
  2. 2.
    Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352:1769–1778.PubMedCrossRefGoogle Scholar
  3. 3.
    Adams PC, Barton JC, McLaren GD, et al. Screening for Iron Overload: lessons from the HEIRS Study. Can J Gastro. 2009;23:771–774.Google Scholar
  4. 4.
    Ulmer FC. The Hawthorne effect. Educ Dir Dent Aux. 1976;1:28.PubMedGoogle Scholar
  5. 5.
    Wolfe F, Michaud K. The Hawthorne effect, sponsored trials, and the overestimation of treatment effectiveness. J Rheumatol. 2010;37:2216–2220.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Natasha Chandok
    • 1
  • Mark Speechley
    • 2
  • Peter J. Ainsworth
    • 3
  • Subrata Chakrabarti
    • 4
  • Paul C. Adams
    • 1
  1. 1.Department of Medicine, University HospitalUniversity of Western OntarioLondonCanada
  2. 2.Department of Epidemiology and BiostatisticsUniversity of Western OntarioLondonCanada
  3. 3.Department of BiochemistryUniversity of Western OntarioLondonCanada
  4. 4.Department of PathologyUniversity of Western OntarioLondonCanada

Personalised recommendations